Amino Acid Profile of Luminal A and B Subtypes Breast Cancer

Sonar Soni Panigoro, Arif Kurniawan, Ramadhan Ramadhan, Ninik Sukartini, Herqutanto Herqutanto, Rafika Indah Paramita, Ferry Sandra

Abstract


BACKGROUND: Amino acids are important for proliferation and maintenance of tumor cells. Breast cancer patients were found to have significant changes in the number of amino acids, which are assumed to be correlated with the molecular subtypes of breast cancer. Therefore, current study was conducted to analyze plasma amino acids in breast cancer patients with luminal A and B subtypes.

METHODS: Breast cancer and control subjects were recruited, and venous blood was collected for the measurement of plasma amino acids. Total 19 plasma amino acids were measured using reverse-phase high-performance liquid chromatography with C18 column. Mean comparison for normally distributed and homogeneous data was further analzyed using independent sample T-test, with p<0.05 was considered as significant.

RESULTS: From total 19 amino acids, only 7 amino acids; cysteine, glutamic acid, histidine, ornithine, threonine, tyrosine, valine, were statistically different between the healthy control and breast cancer subjects. Eventhough no amino acids was found to be statistically different between breast cancer subjects with luminal A and B subtypes, but some amino acids were found to be significantly different when correlated to various breast cancer risk factors.

CONCLUSION: Amino acid profile of patients with Luminal A and B subtypes of breast cancer differs compared to healthy controls and is also correlated with breast cancer risk factors. Increase in cysteine level in Luminal A subtype patients and decrease of alanine and leucine in Luminal B subtype patients can be used as a biomarker.

KEYWORDS: amino acid, plasma, breast cancer, risk factor, biomarker


Full Text:

PDF

References


Savitri M, Bintoro UY, Sedana MP, Diansyah MN, Romadhon PZ, Amrita PNA, et al. Circulating plasma miRNA-21 as a superior biomarker compared to ca 15-3: assessment in healthy age matched subjects and different stage of breast cancer patients. Indones Biomed J. 2020; 12(2): 157-64, CrossRef.

Purwanto I, Heriyanto DS, Ghozali A, Widodo I, Dwiprahasto I, Aryandono T, et al. Basal-like subgroup is associated with younger age, increased expression of androgen receptor, and worse prognosis, while non-basal-like subtype is associated with higher BMI in triple-negative breast cancer patients. Indones Biomed J. 2020; 12(4): 349-54, CrossRef.

Widowati W, Jasaputra DK, Sumitro SB, Widodo MA, Afifah E, Rizal R, et al. Direct and indirect effect of TNFα and IFNγ toward apoptosis in breast cancer cells. Mol Cell Biomed Sci. 2018; 2(2): 60-9, CrossRef.

Abdihalim TS, Idris AAA. Mucin level as a potential biomarker for breast cancer diagnosis. Mol Cell Biomed Sci. 2022; 6(3): 117-20, CrossRef.

Ilyan T, Retnoningrum D, Hendrianingtyas M, Widyaningrum D, Rachmawati B. Association of 25-hydroxyvitamin D, cyclooxygenase-2 and prostaglandin E2 serum levels in breast cancer patients. Indones Biomed J. 2021; 13(4): 426-32, CrossRef.

Remelia M, Bela B, Widyaningtyas ST, Antarianto RD, Mazfufah NF, Pawitan JA. The use of cell-penetrating peptide for delivery of recombinant transcription factor DNA into primary human fibroblast. Mol Cell Biomed Sci. 2023; 7(1): 28-37, CrossRef.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3): 209-49, CrossRef.

Kraeima J, Siesling S, Vliegen IM, Klaase JM, IJzerman MJ. Individual risk profiling for breast cancer recurrence: towards tailored follow-up schemes. Br J Cancer. 2013; 109(4): 866-71, CrossRef.

Retnowarnadi A, Kresno SB, Arif M. Association of obesity and breast cancer risk: The role of estrogen, tumor necrosis factor-alpha, and adiponectin as risk factors (preliminary study). Indones Biomed J. 2009; 1(1): 45-52, CrossRef.

Kimball SR, Jefferson LS. Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr. 2006; 136(1): 227S-31S, CrossRef.

Cha Y, Kim ES, Koo J. Amino acid transporters and glutamine metabolism in breast cancer. Int J Mol Sci. 2018; 19(3): 907, CrossRef.

Saito Y, Soga T. Amino acid transporters as emerging therapeutic targets in cancer. Cancer Sci. 2021; 112(8): 2958-65, CrossRef.

Barnes T, Bell K, DiSebastiano KM, Vance V, Hanning R, Russell C, et al. Plasma amino acid profiles of breast cancer patients early in the trajectory of the disease differ from healthy comparison groups. Appl Physiol Nutr Metab. 2014; 39(6): 740-4, CrossRef.

Poschke I, Mao Y, Kiessling R, De Boniface J. Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes. J Transl Med. 2013; 11(1): 1–9, CrossRef.

Laposata M. Laposata’s Laboratory Medicine Diagnosis of Disease in Clinical Laboratory. 3rd Edition. Columbus: McGraw-Hill Education; 2018, NLMID.

Geck RC, Toker A. Nonessential amino acid metabolism in breast cancer. Adv Biol Regul. 2016; 62: 11-7, CrossRef.

Yang L, Wang Y, Cai H, Wang S, Shen Y, Ke C. Application of metabolomics in the diagnosis of breast cancer : a systematic review. J Cancer. 2020; 11(9): 2540-51, CrossRef.

Rudzińska M, Parodi A, Soond SM, Vinarov AZ, Korolev DO, Morozov AO, et al. The role of cysteine cathepsins in cancer progression and drug resistance. Int J Mol Sci. 2019; 20(14): 3602, CrossRef.

Vettore L, Westbrook RL, Tennant DA. New aspects of amino acid metabolism in cancer. Br J Cancer. 2020; 122: 150-6, CrossRef.

Mitra D. Investigating the Role of Alanine Aminotransferase 2 in Breast Cancer [Dissertation]. Heidelberg: University of Heidelberg; 2018, article.

Tsujimoto M, Goto Y, Maruyama M, Hattori A. Biochemical and enzymatic properties of the M1 family of aminopeptidases involved in the regulation of blood pressure. Heart Fail Rev. 2008; 13(3): 285-91, CrossRef.

Fang C, Zhang J, Yang H, Peng L, Wang K, Wang Y, et al. Leucine aminopeptidase 3 promotes migration and invasion of breast cancer cells through upregulation of fascin and matrix metalloproteinases-2/9 expression. J Cell Biochem. 2019; 120(3): 3611-20, CrossRef.

Lieu EL, Nguyen T, Rhyne S, Kim J. Amino acids in cancer. Exp Mol Med. 2020; 52(1): 15-30, CrossRef.




DOI: https://doi.org/10.18585/inabj.v15i3.2109

Copyright (c) 2023 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

Indexed by:

                  

               

                   

 

 

The Prodia Education and Research Institute